Close Menu

NEW YORK — Aetna this week updated its coverage policy to include noninvasive prenatal testing (NIPT) for all pregnancies.

According to Aetna's updated policy, the Hartford, Connecticut-based insurer now considers NIPT using measurement of cell-free fetal nucleic acids in maternal blood to be medically necessary for screening for fetal aneuploidy in all pregnant women.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.